US2019216773A1PendingUtilityA1

Methods to mobilize progenitor/stem cells

67
Assignee: GENZYME CORPPriority: Jul 31, 2001Filed: Aug 21, 2018Published: Jul 18, 2019
Est. expiryJul 31, 2021(expired)· nominal 20-yr term from priority
A61P 7/06A61P 31/12A61P 9/00A61P 37/00A61P 43/00A61P 37/04A61P 31/04A61P 35/02A61P 7/00A61P 17/02A61K 31/4427A61K 31/496C12N 5/0647A61K 31/33A61K 31/55A61K 38/193A61K 31/551A61K 31/555A61K 38/195A61K 35/28A61K 2035/124A61K 31/395
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods to elevate progenitor and stem cell counts in animal subjects using compounds which bind to the chemokine receptor CXCR4 are disclosed. Preferred embodiments of such compounds are of the formula Z-linker-Z′  (1) or pharmaceutically acceptable salt thereof wherein Z is a cyclic polyamine containing 9-32 ring members of which 3-8 are nitrogen atoms, said nitrogen atoms separated from each other by at least 2 carbon atoms, and wherein said heterocycle may optionally contain additional heteroatoms besides nitrogen and/or may be fused to an additional ring system; or Z is of the formula wherein A comprises a monocyclic or bicyclic fused ring system containing at least one N and B is H or an organic moiety of 1-20 atoms, Z′ may be embodied in a form as defined by Z above, or alternatively may be of the formula —N(R)—(CR 2 ) n —X wherein each R is independently H or straight, branched or cyclic alkyl (1-6C), n is 1 or 2, and X is an aromatic ring, including heteroaromatic rings, or is a mercaptan; “linker” represents a bond, alkylene (1-6C) or may comprise aryl, fused aryl, oxygen atoms contained in an alkylene chain, or may contain keto groups or nitrogen or sulfur atoms.

Claims

exact text as granted — not AI-modified
1 - 3 . (canceled) 
     
     
         4 . A method of enhancing wound healing, comprising administering to a subject 1,1′-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane in an amount effective to mobilize progenitor and/or stem cells into the peripheral blood of said subject. 
     
     
         5 . A method of treating burns, comprising administering to a subject 1,1′-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane in an amount effective to mobilize progenitor and/or stem cells into the peripheral blood of said subject. 
     
     
         6 . A method of treating bacterial inflammation, comprising administering to said subject 1,1′-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane in an amount effective to mobilize progenitor and/or stem cells into the peripheral blood of said subject.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.